• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·ODTX
Share

Odyssey Therapeutics, Inc. Stocks

$ 18.55Last Updated 23.06.2026

Issuer Rating

Performance

Average

Risk

Considerable

Recommendation

Sell

Market Cap

$ 570.87M

$ 18.55
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only

Profitability factor

Favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Latest news

08.05.2026 15:00

Odyssey IPO: Immune system biotech debuts on the Nasdaq

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

No company description

Target Price

Favourable
6/7

The average target price of ODTX is 34 and suggests 79.5% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

25.06.2026 00:15

A South Korean supplier of Nvidia is going public on the Nasdaq. What does this mean for its competitors?

24.06.2026 23:34

Deal in the Rare Earth Metals Market: U.S. Mid-Cap Company Aims to Compete with China

24.06.2026 23:10

OpenAI and Broadcom have unveiled a new chip that will cut the cost of running AI in half

24.06.2026 22:40

S&P Raised the Credit Ratings of Four Freedom Subsidiaries with a Stable Outlook

24.06.2026 22:19

Shares of Nvidia's competitor plummeted 17% following the earnings report. What spooked investors?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026